fda warning letter semaglutide october 2025 Novo's Wegovy and Ozempic removed from US shortage list, compounders on notice FDA issues warning to Novo

The application of cytokeratin-18 as a biomarker for drug-induced liver injury

Plus, an array of weight loss options from compounded GLP-1 injections to custom oral medication kits reviewed and prescribed by a licensed healthcare provider and/or a custom blend of doctor-trusted ingredients, each shown to promote weight loss

Stability of protein pharmaceuticals: an update

"It's really helped our patients with Type 2 diabetes really get their disease under control, decrease their weight and then improve their overall health and metabolic health," said Narang, an endocrinologist and director of obesity medicine at Northwestern Medicine Lake Forest Hospital